1. Home
  2. STOK vs NPWR Comparison

STOK vs NPWR Comparison

Compare STOK & NPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • NPWR
  • Stock Information
  • Founded
  • STOK 2014
  • NPWR 2010
  • Country
  • STOK United States
  • NPWR United States
  • Employees
  • STOK N/A
  • NPWR N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • NPWR Industrial Machinery/Components
  • Sector
  • STOK Health Care
  • NPWR Energy
  • Exchange
  • STOK Nasdaq
  • NPWR Nasdaq
  • Market Cap
  • STOK 721.4M
  • NPWR 665.3M
  • IPO Year
  • STOK 2019
  • NPWR N/A
  • Fundamental
  • Price
  • STOK $12.03
  • NPWR $12.67
  • Analyst Decision
  • STOK Strong Buy
  • NPWR Hold
  • Analyst Count
  • STOK 7
  • NPWR 2
  • Target Price
  • STOK $21.40
  • NPWR $9.50
  • AVG Volume (30 Days)
  • STOK 405.8K
  • NPWR 754.9K
  • Earning Date
  • STOK 11-05-2024
  • NPWR 11-11-2024
  • Dividend Yield
  • STOK N/A
  • NPWR N/A
  • EPS Growth
  • STOK N/A
  • NPWR N/A
  • EPS
  • STOK N/A
  • NPWR 0.11
  • Revenue
  • STOK $16,742,999.00
  • NPWR $250,000.00
  • Revenue This Year
  • STOK $91.67
  • NPWR N/A
  • Revenue Next Year
  • STOK $5.45
  • NPWR $7,463.34
  • P/E Ratio
  • STOK N/A
  • NPWR $119.91
  • Revenue Growth
  • STOK 81.08
  • NPWR 38.12
  • 52 Week Low
  • STOK $3.77
  • NPWR $6.57
  • 52 Week High
  • STOK $17.58
  • NPWR $14.28
  • Technical
  • Relative Strength Index (RSI)
  • STOK 39.51
  • NPWR 75.83
  • Support Level
  • STOK $13.39
  • NPWR $8.63
  • Resistance Level
  • STOK $14.72
  • NPWR $14.28
  • Average True Range (ATR)
  • STOK 0.68
  • NPWR 0.92
  • MACD
  • STOK 0.03
  • NPWR 0.40
  • Stochastic Oscillator
  • STOK 7.24
  • NPWR 72.60

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system which it refers to as the "NET Power Cycle is designed to produce clean, reliable and low-cost electricity from natural gas while capturing virtually all atmospheric emissions.

Share on Social Networks: